HomeAboutSearchContactMember Login
GPBCH Obesity Drug Action Brief March 2019
Obesity is one of the leading chronic disease states in the United States, affecting more than 1 in 3 adults. It is a driver of health care utilization and cost and poorer health outcomes, is closely linked to increasing rates of diabetes, and affects incidence, prevalence, quality of life and other health outcomes, for many other chronic conditions including cardiovascular disease, musculoskeletal decline, and cancer. In this new Action Brief, we explain why employers should consider including obesity drugs in their pharmacy benefit offerings.
Our Partners
National Alliance for Healthcare Purchaser Coalitions     The Leapfrog Group     Delaware Chamber of Commerce     South Jersey Chamber of Commerce     Philadelphia Chamber of Commerce
Recently Tweeted:
The Greater Philadelphia Business Coalition on Health is now on Facebook! To view our page (and follow/like us) cli… https://t.co/U5sbHeru75